|
DEC (n)
|
AMP
|
AK
|
C
|
CN
|
CI
|
CF
|
COT
|
CST
|
MRP
|
NX
|
G
|
CFM
|
DO
|
OF
|
MDR (%)
|
|---|
|
a-EPEC (29)
|
21 (72.4)
|
06 (20.7)
|
14 (48.3)
|
14 (48.3)
|
22 (75.9)
|
10 (34.5)
|
09 (31.0)
|
24 (82.8)
|
06 (20.7)
|
12 (41.4)
|
04 (13.8)
|
21 (72.4)
|
12 (41.4)
|
14 (48.3)
|
14 (48.3)
|
|
t-EPEC (21)
|
14 (66.7)
|
08 (38.1)
|
05 (23.8)
|
12 (57.1)
|
12 (57.1)
|
03 (14.3)
|
08 (38.1)
|
16 (76.2)
|
06 (28.6)
|
09 (42.6)
|
07 (33.3)
|
12 (57.1)
|
12 (57.1)
|
07 (33.3)
|
07 (24.1)
|
|
EIEC (08)
|
07 (87.5)
|
01 (12.5)
|
00 (0)
|
06 (75)
|
07 (87.5)
|
04 (50)
|
07 (87.5)
|
04 (50)
|
05 (62.5)
|
01 (12.5)
|
05 (62.5)
|
05 (62.5)
|
05 (62.5)
|
05 (62.5)
|
03 (37.5)
|
|
Total (58)
|
42 (72.4)
|
15 (25.9)
|
19 (32.8)
|
32 (55.2)
|
41 (70.7)
|
17 (29.3)
|
24 (41.4)
|
44 (75.9)
|
17 (29.3)
|
22 (37.9)
|
16 (27.6)
|
38 (65.5)
|
29 (50)
|
26 (44.8)
|
24 (41.4)
|
- Figures in parenthesis denotes the % of the samples
-
MDR multi drug resistant, a-EPEC atypical enteropathogenic Escherichia coli, t-EPEC typical enteropathogenic Escherichia coli, EIEC enteroinvasive Escherichia coli, μg microgram, Antibiotics ampicillin (AMP10 = 10 μg), amikacin (AK10 = 10 μg), chloramphenicol (C 30 = 30 μg), ceftriaxone (CI 10 = 10 μg), cephalexin (CN30 = 30 μg), ciprofloxacin (CF10 = 10 μg), co-trimoxazole (COT25 = trimethoprim 1.25 μg and sulphamethoxazole 23.75 μg), cefoperazone–tazobactam (CST 75–10 μg), meropenem (MRP10 = 10 μg), norfloxacin (NX10 = 10 μg), gentamicin (G10 = 10 μg), cefixime (CFM 5 = 5 μg), doxycycline hydrochloride (DO10 = 10 μg) and ofloxacin (OF 5 = 5 μg)
